Thyroid News and Research RSS Feed - Thyroid News and Research

Robert Wood Johnson Medical Group physicians selected for Best Doctors in America List for 2015-2016

Robert Wood Johnson Medical Group physicians selected for Best Doctors in America List for 2015-2016

Sixty-one physicians affiliated with Robert Wood Johnson Medical Group, the faculty practice of Rutgers Robert Wood Johnson Medical School, were selected for the Best Doctors in America® List for 2015-2016. Only 5 percent of physicians in the United States earn this prestigious honor, determined by impartial peer review. [More]
Fetal microchimerism could be a subtle and dizzyingly complex puzzle

Fetal microchimerism could be a subtle and dizzyingly complex puzzle

Parents go to great lengths to ensure the health and well-being of their developing offspring. The favor, however, may not always be returned. [More]
PFF, Veracyte partner on U.S. survey exploring patients' diagnostic experiences with interstitial lung diseases

PFF, Veracyte partner on U.S. survey exploring patients' diagnostic experiences with interstitial lung diseases

The Pulmonary Fibrosis Foundation and Veracyte, Inc. announced that the organizations are partnering on a U.S. patient survey to advance understanding of patients' diagnostic experiences with interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF). [More]
Proper iodine nutrition necessary during pregnancy

Proper iodine nutrition necessary during pregnancy

New research published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, found that pregnant women in Sweden had inadequate levels of iodine in their diets. Proper iodine nutrition is necessary for neurological development of the fetus. [More]
Better drug design may soon be aided by Scripps scientists’ discoveries

Better drug design may soon be aided by Scripps scientists’ discoveries

For the first time, they have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output. These new findings could aid future drug design by giving scientists an edge in fine tuning the signal between these partnered proteins—and the drug’s course of action. [More]
New TSRI study may have important implications for better drug design

New TSRI study may have important implications for better drug design

Scientists from The Scripps Research Institute Florida campus have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output. These new findings could aid future drug design by giving scientists an edge in fine tuning the signal between these partnered proteins—and the drug's course of action. [More]
Landmark 'basket study' shows efficacy of vemurafenib in multiple nonmelanoma BRAFV600-mutated cancers

Landmark 'basket study' shows efficacy of vemurafenib in multiple nonmelanoma BRAFV600-mutated cancers

Researchers from Memorial Sloan Kettering Cancer Center have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients' tumors rather than where their cancer originated. [More]
Risk of hepatobiliary cancer higher in women with intrahepatic cholestasis of pregnancy

Risk of hepatobiliary cancer higher in women with intrahepatic cholestasis of pregnancy

In a new study of more than 125,000 pregnant women in Sweden, researchers at the Sahlgrenska Academy found that the risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later in life is higher in women with intrahepatic cholestasis of pregnancy (ICP) than in women without this condition. [More]
Older patients more likely to be readmitted to hospital after ambulatory surgery

Older patients more likely to be readmitted to hospital after ambulatory surgery

Patients 65 and older who have ambulatory surgery are much more likely to be readmitted to the hospital within 30 days than younger patients, regardless of their health before surgery, reports a new, large national Northwestern Medicine study. The likely cause, based on previous research, is difficulty understanding medication dosing and discharge instructions, as well as cognitive impairment among older patients. [More]
MSK and LVHN collaborate to improve patients’ access to innovative cancer treatments

MSK and LVHN collaborate to improve patients’ access to innovative cancer treatments

Memorial Sloan Kettering Cancer Center (MSK) and Lehigh Valley Health Network (LVHN) announced today the beginning of a unique and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and highest-caliber cancer care. [More]
Array Biopharma reports strong fourth quarter and full year 2015 financial results

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Array BioPharma Inc. today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015. [More]
Lancet Series examines enduring radiological, psychological impact of nuclear disasters

Lancet Series examines enduring radiological, psychological impact of nuclear disasters

On the 70th anniversary of the atomic bombs in Hiroshima and Nagasaki, a three-part Series published in The Lancet looks at the enduring radiological and psychological impact of nuclear disasters, including the most recent accident at the Fukushima Daiichi nuclear power plant in Japan in 2011. [More]
CMC Biologics, River Vision sign manufacturing agreement for Teprotumumab to treat Grave's Orbitopathy

CMC Biologics, River Vision sign manufacturing agreement for Teprotumumab to treat Grave's Orbitopathy

CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River Vision), a private company focused on ophthalmology, announced today that they have entered into an agreement for the process transfer and cGMP production of RV001 (Teprotumumab) – a recombinant monoclonal antibody targeting insulin-like growth factor 1 that is in development for treatment of Grave's Orbitopathy and other indications. [More]
Endocrine Society selects 18 endocrinologists as winners of 2016 Laureate Awards

Endocrine Society selects 18 endocrinologists as winners of 2016 Laureate Awards

The Endocrine Society today announced it has chosen 18 accomplished endocrinologists as winners of the organization's prestigious 2016 Laureate Awards. [More]
Mayo Clinic researchers study HDAC inhibitors to find effective treatments for anaplastic thyroid cancer

Mayo Clinic researchers study HDAC inhibitors to find effective treatments for anaplastic thyroid cancer

In their bid to find the best combination of therapies to treat anaplastic thyroid cancer (ATC), researchers on Mayo Clinic's Florida campus demonstrated that all histone deacetylase (HDAC) inhibitors are not created equal. [More]
Brown University explores effect of chemical exposures on the brain and thyroid during pregnancy, childhood

Brown University explores effect of chemical exposures on the brain and thyroid during pregnancy, childhood

Exposure to the endocrine disrupting chemicals bisphenol A, triclosan and phthalates is ubiquitous in the United States, raising concerns that they may affect health. With a new four-year, $1.5 million grant from the National Institutes of Health, Brown University epidemiologist Joseph Braun will try to close a gap in research: the effect of these exposures on the brain and thyroid during pregnancy and childhood. [More]
Phase 3 SUMIT study: Selumetinib fails to meet primary endpoint in patients with metastatic uveal melanoma

Phase 3 SUMIT study: Selumetinib fails to meet primary endpoint in patients with metastatic uveal melanoma

AstraZeneca today announced that the Phase 3 SUMIT study of selumetinib in combination with dacarbazine for the treatment of patients with metastatic uveal melanoma did not meet its primary endpoint of progression free survival. This combination therapy showed an adverse event profile generally consistent with current knowledge of the safety profiles of dacarbazine and selumetinib. [More]
Invuity's proprietary photonics technology recognized for improving patient safety

Invuity's proprietary photonics technology recognized for improving patient safety

Invuity, Inc., a leading surgical photonics company, today reported that The Joint Commission has recognized its proprietary photonics technology as an important innovation in the prevention of unintended retained foreign objects (URFOs) that are left inside patients during surgery. [More]
Study shows that moderate suppression of TSH may be enough even in high-risk thyroid cancer

Study shows that moderate suppression of TSH may be enough even in high-risk thyroid cancer

A study of long-term thyroid cancer outcomes shows, among other findings, that moderate suppression of thyroid-stimulating hormone (TSH), which drives the disease, may be as beneficial as more extreme hormone suppression. [More]
UT Southwestern dermatologist improves technique to treat skin discoloration from vitiligo

UT Southwestern dermatologist improves technique to treat skin discoloration from vitiligo

A UT Southwestern Medical Center dermatologist has improved a technique to transplant pigment cells that can repair the affected area of skin discoloration from vitiligo. [More]
Advertisement
Advertisement